ZYMEWORKS INC. Increase (Decrease) in Deferred Income Taxes
ZYMEWORKS INC. (ZYME) reported Increase (Decrease) in Deferred Income Taxes of $1.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2026-08-06
- ZYMEWORKS INC. increase (decrease) in deferred income taxes for the quarter ending 2026-06-30 was -$265.00K.
- ZYMEWORKS INC. increase (decrease) in deferred income taxes for the quarter ending 2026-03-31 was $2.20M, a 436.59% increase year-over-year.
- ZYMEWORKS INC. increase (decrease) in deferred income taxes for the quarter ending 2025-12-31 was -$1.41M.
- ZYMEWORKS INC. increase (decrease) in deferred income taxes for the quarter ending 2025-09-30 was $170.00K, a 16.67% decline year-over-year.
- ZYMEWORKS INC. increase (decrease) in deferred income taxes for fiscal 2025 was -$945.00K.
- ZYMEWORKS INC. increase (decrease) in deferred income taxes for fiscal 2024 was -$691.00K, a 191.28% decline from fiscal 2023.
- ZYMEWORKS INC. increase (decrease) in deferred income taxes for fiscal 2023 was $757.00K.
- ZYMEWORKS INC. increase (decrease) in deferred income taxes for fiscal 2022 was -$1.94M, a 303.57% decline from fiscal 2021.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$265.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.94M 10-Q · filed 2026-08-06 | $525.00K derived: sum of 3 quarters · filed 2026-08-06 | $695.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.20M 10-Q · filed 2026-05-07 | $790.00K derived: sum of 2 quarters · filed 2026-05-07 | $960.00K derived: sum of 3 quarters · filed 2026-05-07 | $845.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$1.24M derived: sum of 2 quarters · filed 2026-03-02 | -$1.35M derived: sum of 3 quarters · filed 2026-08-06 | -$945.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $55.00K derived: sum of 2 quarters · filed 2026-08-06 | $465.00K 10-Q · filed 2025-11-06 | -$662.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $295.00K 10-Q · filed 2026-08-06 | -$832.00K derived: sum of 3 quarters · filed 2026-08-06 | -$628.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $410.00K 10-Q · filed 2026-05-07 | -$717.00K derived: sum of 2 quarters · filed 2026-05-07 | -$513.00K derived: sum of 3 quarters · filed 2026-05-07 | -$319.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$923.00K derived: sum of 2 quarters · filed 2026-03-02 | -$729.00K derived: sum of 3 quarters · filed 2026-03-02 | -$691.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $398.00K derived: sum of 2 quarters · filed 2025-11-06 | $436.00K 10-Q · filed 2025-11-06 | $1.40M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $232.00K 10-Q · filed 2025-08-07 | $1.20M derived: sum of 3 quarters · filed 2026-03-02 | $1.10M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $38.00K 10-Q · filed 2025-05-08 | $1.00M derived: sum of 2 quarters · filed 2026-03-02 | $910.00K derived: sum of 3 quarters · filed 2026-03-02 | $804.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $967.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $872.00K derived: sum of 2 quarters · filed 2026-03-02 | $766.00K derived: sum of 3 quarters · filed 2026-03-02 | $757.00K 10-K · filed 2026-03-02 |
| 2023-09-30 | -$95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$201.00K derived: sum of 2 quarters · filed 2024-10-31 | -$210.00K 10-Q · filed 2024-10-31 | -$2.09M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | -$106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$115.00K 10-Q · filed 2024-08-01 | -$2.00M derived: sum of 3 quarters · filed 2025-03-05 | -$1.58M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | -$9.00K 10-Q · filed 2024-05-02 | -$1.89M derived: sum of 2 quarters · filed 2025-03-05 | -$1.48M derived: sum of 3 quarters · filed 2025-03-05 | -$1.21M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$1.47M derived: sum of 2 quarters · filed 2025-03-05 | -$1.21M derived: sum of 3 quarters · filed 2025-03-05 | -$1.94M 10-K · filed 2025-03-05 |
| 2022-09-30 | $411.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $676.00K derived: sum of 2 quarters · filed 2023-11-07 | -$59.00K 10-Q · filed 2023-11-07 | $1.20M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | $265.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$470.00K 10-Q · filed 2023-08-10 | $786.00K derived: sum of 3 quarters · filed 2024-03-06 | |
| 2022-03-31 | -$735.00K 10-Q · filed 2023-05-08 | $521.00K derived: sum of 2 quarters · filed 2024-03-06 | ||
| 2021-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $953.00K 10-K · filed 2024-03-06 | ||
| 2021-09-30 | -$303.00K 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | -$266.00K 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |